Home > Products > CD20 & CD22
> Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scIgG)
Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scIgG) (CAT#: SCIGG-049)
Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD20 and anti-CD22 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scIgG) (SCIGG-049). Click the button below to contact us or submit your feedback about this product.